Intrinsic Value

The intrinsic value of Astrana Health Inc (ASTH) under the Base Case is 44.06 USD per share. Compared with the current market price of 36.755 USD, the stock appears Undervalued by 17% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

ASTH Intrinsic Value
$44.06
Undervaluation 17%
Intrinsic Value
Price $36.755

ASTH is valued in line with its history. A discount of this size has been typical over the past 5 years.

Monitor ASTH
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $35.25
Get notified when the price drops into your buy zone
Intrinsic Value $44.06
Current Price $36.76
Margin of Safety 20% $35.25
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to ASTH

Fundamental Analysis

What Astrana Health Does

Health Care

Apollo Medical Holdings, also known as ApolloMed, is a physician-led healthcare company that helps manage patient care for health plans, hospitals, and other risk-bearing medical groups. It works through affiliated doctors and care teams that handle primary care, hospital visits, specialist coordination, and post-acute care for patients who need closely managed treatment.

Headquarters
United States of America US
Employees
3 000
IPO date
Apr 9, 1999
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Astrana Health Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one ASTH stock?

The intrinsic value for Astrana Health Inc (ASTH) under the Base Case is 44.06 USD.

Is ASTH stock undervalued or overvalued?

Compared with the current market price of 36.755 USD, the stock appears Undervalued by 17% .

Back to Top